Literature DB >> 20016036

Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic.

David A Boltz1, Bounlom Douangngeun, Phouvong Phommachanh, Settha Sinthasak, Ricarda Mondry, Caroline Obert, Patrick Seiler, Rachael Keating, Yasuo Suzuki, Hiroaki Hiramatsu, Elena A Govorkova, Robert G Webster.   

Abstract

Pandemic influenza viruses can emerge through continuous evolution and the acquisition of specific mutations or through reassortment. This study assessed the pandemic potential of H5N1 viruses isolated from poultry outbreaks occurring from July 2006 to September 2008 in the Lao People's Democratic Republic (PDR). We analyzed 29 viruses isolated from chickens and ducks and two from fatal human cases in 2007. Prior to 2008, all H5N1 isolates in Lao PDR were from clade 2.3.4; however, clade 2.3.2 was introduced in September 2008. Of greatest concern was the circulation of three isolates that showed reduced sensitivity to the neuraminidase (NA) inhibitor oseltamivir in an enzyme inhibition assay, each with different NA mutations - V116A, I222L and K150N, and a previously unreported S246N mutation. In addition, six isolates had an S31N mutation in the M2 protein, which conferred resistance to amantadine not previously reported in clade 2.3.4 viruses. Two H5N1 reassortants were isolated whose polymerase genes, PB1 and PB2, were homologous to those of Eurasian viruses giving rise to a novel H5N1 genotype, genotype P. All H5N1 viruses retained avian-like receptor specificity, but four had altered affinities for alpha2,3-linked sialic acid. This study shows that, in a genetically similar population of H5N1 viruses in Lao PDR, mutants emerged with natural resistance to antivirals and altered affinities for alpha2,3-linked sialic acids, together with reassortants with polymerase genes homologous to Eurasian viruses. These changes may contribute to the emergence of a pandemic influenza strain and are critical in devising surveillance strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20016036      PMCID: PMC2888158          DOI: 10.1099/vir.0.017459-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  41 in total

1.  Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase.

Authors:  P M Colman; P A Hoyne; M C Lawrence
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

2.  Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?

Authors:  Y Guan; K F Shortridge; S Krauss; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

3.  Universal primer set for the full-length amplification of all influenza A viruses.

Authors:  E Hoffmann; J Stech; Y Guan; R G Webster; D R Perez
Journal:  Arch Virol       Date:  2001-12       Impact factor: 2.574

4.  H5N1 influenza viruses isolated from geese in Southeastern China: evidence for genetic reassortment and interspecies transmission to ducks.

Authors:  Y Guan; M Peiris; K F Kong; K C Dyrting; T M Ellis; T Sit; L J Zhang; K F Shortridge
Journal:  Virology       Date:  2002-01-05       Impact factor: 3.616

5.  Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.

Authors:  G Köhler; C Milstein
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

6.  Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

Authors:  K S Li; Y Guan; J Wang; G J D Smith; K M Xu; L Duan; A P Rahardjo; P Puthavathana; C Buranathai; T D Nguyen; A T S Estoepangestie; A Chaisingh; P Auewarakul; H T Long; N T H Hanh; R J Webby; L L M Poon; H Chen; K F Shortridge; K Y Yuen; R G Webster; J S M Peiris
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

7.  Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003.

Authors:  Taisuke Horimoto; Nao Fukuda; Kiyoko Iwatsuki-Horimoto; Yi Guan; Wilina Lim; Malik Peiris; Shunji Sugii; Takato Odagiri; Masato Tashiro; Yoshihiro Kawaoka
Journal:  J Vet Med Sci       Date:  2004-03       Impact factor: 1.267

8.  H5N1 influenza: a protean pandemic threat.

Authors:  Y Guan; L L M Poon; C Y Cheung; T M Ellis; W Lim; A S Lipatov; K H Chan; K M Sturm-Ramirez; C L Cheung; Y H C Leung; K Y Yuen; R G Webster; J S M Peiris
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

9.  Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus.

Authors:  T Horimoto; Y Kawaoka
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  The evolution of H5N1 influenza viruses in ducks in southern China.

Authors:  H Chen; G Deng; Z Li; G Tian; Y Li; P Jiao; L Zhang; Z Liu; R G Webster; K Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-02       Impact factor: 11.205

View more
  48 in total

1.  Diversifying evolution of highly pathogenic H5N1 avian influenza virus in Egypt from 2006 to 2011.

Authors:  E M Abdelwhab; Abdel-Satar Arafa; Jürgen Stech; Christian Grund; Olga Stech; Marcus Graeber-Gerberding; Martin Beer; Mohamed K Hassan; Mona M Aly; Timm C Harder; Hafez M Hafez
Journal:  Virus Genes       Date:  2012-06-05       Impact factor: 2.332

2.  Emergence of mammalian species-infectious and -pathogenic avian influenza H6N5 virus with no evidence of adaptation.

Authors:  Jeong-Hyun Nam; Eun-Ha Kim; Daesub Song; Young Ki Choi; Jeong-Ki Kim; Haryoung Poo
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

3.  Emerging influenza antiviral resistance threats.

Authors:  Frederick G Hayden; Menno D de Jong
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

4.  Ancestral and Compensatory Mutations that Promote Antiviral Resistance in Influenza N1 Neuraminidase Revealed by a Phylonumerics Approach.

Authors:  Elma H Akand; Kevin M Downard
Journal:  J Mol Evol       Date:  2018-10-09       Impact factor: 2.395

5.  Evolution and control of H5N1. A better understanding of the evolution and diversity of H5N1 flu virus and its host species in endemic areas could inform more efficient vaccination and control strategies.

Authors:  Yohei Watanabe; Madiha S Ibrahim; Kazuyoshi Ikuta
Journal:  EMBO Rep       Date:  2013-01-11       Impact factor: 8.807

6.  Pseudovirus-based neuraminidase inhibition assays reveal potential H5N1 drug-resistant mutations.

Authors:  Yi Lu; Taijiao Jiang
Journal:  Protein Cell       Date:  2013-04-15       Impact factor: 14.870

7.  Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.

Authors:  Min-Suk Song; Bindumadhav M Marathe; Gyanendra Kumar; Sook-San Wong; Adam Rubrum; Mark Zanin; Young-Ki Choi; Robert G Webster; Elena A Govorkova; Richard J Webby
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

8.  Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virus.

Authors:  M Naughtin; J C Dyason; S Mardy; S Sorn; M von Itzstein; P Buchy
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

9.  Effect of oseltamivir carboxylate consumption on emergence of drug-resistant H5N2 avian influenza virus in Mallard ducks.

Authors:  Jenna E Achenbach; Richard A Bowen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

10.  Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.

Authors:  Elena A Govorkova; Tatiana Baranovich; Patrick Seiler; Jianling Armstrong; Andrew Burnham; Yi Guan; Malik Peiris; Richard J Webby; Robert G Webster
Journal:  Antiviral Res       Date:  2013-02-28       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.